BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

broker report

  1. supertramp
    11,795 Posts.
    lightbulb Created with Sketch. 1727
    clock Created with Sketch.
    14/12/07
    11:32
    Post #: 3160323
    I don't hold, but intersuisse has put out a buy on bno today:

    Bionomics Limited BNO Friday, 14 December 2007
    The First Phase I Clinical Trial To Commence Soon!
    Recommendation Speculative Buy Target Price $0.56


    Historically, Australian biotechnology companies experience a strong upswing in the share price as speculative investors postulate on the outcome of the Phase I trial and sophisticated investors take a position due to the decreasing downside risk and higher probability of returns in the form of license agreements.
    We retain Bionomics as a Speculative Buy, to the investor knowledgeable and tolerant of the risks associated with biotechnology stocks.
    BNO Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Strategic investment secured for QLD and NSW bauxite projects
right-arrow Created with Sketch.
NEWS New channel sampling confirms further copper at Graceland, Namibia
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Marquee declares maiden antimony resource at Eastern Hills with phase two exploration to commence
right-arrow Created with Sketch.
NEWS Drilling to commence at FAU’s Gimlet high-grade gold project following approvals
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.